Search

Aldeyra Therapeutics Inc

Deschisă

0.59 -14.49

Rezumat

Modificarea prețului

24h

Curent

Minim

0.6

Maxim

0.7

Indicatori cheie

By Trading Economics

Venit

-2M

-5.5M

EPS

-0.16

Angajați

6

EBITDA

-2.5M

-5.4M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+222.58% upside

Dividende

By Acuity

Următoarele câștiguri

10 nov. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-57M

35M

Deschiderea anterioară

15.08

Închiderea anterioară

0.59

Aldeyra Therapeutics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

3 nov. 2026, 23:56 UTC

CF Industries Holdings Inc shares advanced in after-market trading, recovering from a recent downward trend following a notable uptick after the market closed.

3 nov. 2026, 23:56 UTC

Krispy Kreme, Inc. shares declined modestly during after-market hours on Tuesday, slipping from an initial high but remaining above its 20-day moving average.

3 nov. 2026, 23:56 UTC

Correlated Moves

Ichor Holdings, Ltd. is trading lower in after-market hours, continuing a decline to its lowest point of the day amid stronger U.S. economic indicators.

3 nov. 2026, 23:56 UTC

News

Taco Bell's U.S. sales show signs of recovery after outbreak.

3 nov. 2026, 23:56 UTC

News
Social Media

GXO Logistics reported Q3 net income of $65 million and adjusted EPS of $0.89, exceeding expectations, but operating income fell to $96 million.

3 nov. 2026, 23:56 UTC

Sigma Lithium Corp is higher in after-market trading, recovering from earlier lows and advancing since Tuesday's close.

3 nov. 2026, 23:56 UTC

Take-Two Interactive Software, Inc. is trading modestly higher in after-market hours, continuing an upward trend observed over the last three sessions.

3 nov. 2026, 23:52 UTC

SiteOne Landscape Supply Inc is trading higher in after-market hours, reaching its peak for the day following a strong performance over the past month.

3 nov. 2026, 23:52 UTC

Shares of the fund are trading higher in after-market hours, rebounding from a low shortly after the regular session ended.

3 nov. 2026, 23:52 UTC

ISM Services PMI for October 2026 set to release on November 4, with a forecast of 54.8 indicating continued non-manufacturing sector expansion amid mixed economic signals and rising interest rates.

3 nov. 2026, 23:52 UTC

UK Retail Sales Monitor YoY for October 2026 Expected to Show Growth Amid Inflation Concerns and Holiday Shopping Optimism.

3 nov. 2026, 23:51 UTC

Dolby Laboratories, Inc. is declining in after-market trading, hitting its lowest point of the day.

3 nov. 2026, 23:51 UTC

MakeMyTrip Limited is trading modestly higher in after-market hours, having risen sharply since Tuesday's close to reach its highest cumulative return of the day.

3 nov. 2026, 23:51 UTC

Halozyme Therapeutics, Inc. is moving lower in after-market trading, retracing from a brief high and currently near the lower end of its recent performance range.

3 nov. 2026, 23:51 UTC

Ally Financial Inc. is trading modestly higher in after-market hours, showing notable strength since Tuesday's close and positioning around the middle of its one-month trading range.

3 nov. 2026, 23:51 UTC

Metropolitan Bank Holding Corp shares are declining in after-market trading, moving lower from a minor peak shortly after the regular session ended.

3 nov. 2026, 23:51 UTC

UGI Corporation shares are trading modestly higher in after-market hours, reflecting broader market gains driven by strong economic indicators and rising U.S. Treasury yields.

3 nov. 2026, 23:51 UTC

Equity LifeStyle Properties Inc's shares fell during after-market hours on Tuesday, breaking a recent trend of higher daily closes.

3 nov. 2026, 23:51 UTC

Vail Resorts, Inc. is trading higher in after-market hours, maintaining a slight gain since Tuesday's close and remaining above its 20-day moving average.

3 nov. 2026, 23:51 UTC

Correlated Moves

Morgan Stanley's shares traded modestly lower in after-market hours, despite a positive move in the Nasdaq 100 Index following strong U.S. economic indicators.

3 nov. 2026, 23:51 UTC

Social Media
News

Palantir Technologies reported better-than-expected Q3 2026 earnings and revenue, but shares declined amid concerns over total growth slowdown.

3 nov. 2026, 23:51 UTC

Social Media

UnitedHealth Group has authorized up to 50 million additional shares for repurchase, while the stock has traded modestly lower in after-market hours.

3 nov. 2026, 23:51 UTC

Lindblad Expeditions Holdings, Inc. is trading higher in after-market hours, recovering from a dip earlier in the session since Tuesday's close.

3 nov. 2026, 23:51 UTC

Fidelity National Information Services, Inc. is advancing in after-market trading, showing notable strength since Tuesday's close and reaching a high above its 20-day moving average.

3 nov. 2026, 23:51 UTC

News

MercadoLibre shares are trading modestly higher in after-market hours ahead of its third quarter earnings report on November 4.

3 nov. 2026, 23:51 UTC

ACNB Corp's shares advanced in after-market trading, rising significantly since Tuesday's close and positioning well above its 20-day moving average.

3 nov. 2026, 23:51 UTC

Correlated Moves

Broadcom Inc shares rose in after-market trading, supported by a broader market rally and strong performances from key semiconductor holdings like AMD and NVIDIA.

3 nov. 2026, 23:51 UTC

News

USD/PLN declines, breaking a trend of higher daily closes, amid strong U.S. economic indicators including increased JOLTs Job Openings and Factory Orders.

3 nov. 2026, 23:51 UTC

News

USD/SGD is slightly higher as U.S. durable goods orders held at 0.5%, JOLTs Job Openings rose to 7.523 million, and Factory Orders increased by 1.8%.

3 nov. 2026, 23:51 UTC

GBP/CAD is trading modestly higher as JOLTs Job Openings rose to 7.523 million in September, exceeding forecasts, alongside a 1.8% increase in Factory Orders.

Comparație

Modificare preț

Aldeyra Therapeutics Inc Așteptări

Obiectiv de preț

By TipRanks

222.58% sus

Prognoză pe 12 luni

Medie 2 USD  222.58%

Maxim 2 USD

Minim 2 USD

În baza a 1 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruAldeyra Therapeutics Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

1 ratings

0

Cumpărare

1

Păstrare

0

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Aldeyra Therapeutics Inc

Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases. The company also develops ADX-629, an orally administered RASP modulator for treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment retinitis pigmentosa, as well as rare retinal diseases characterized by inflammation and vision loss. In addition, it develops ADX-246 in systemic immune-mediated disease; and ADX-248 in geographic atrophy. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.
help-icon Live chat